Literature DB >> 11422331

Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes.

D Corda1, P Gelisse, P Genton, C Dravet, M Baldy-Moulinier.   

Abstract

PURPOSE: Benign epilepsy with centrotemporal spikes (BECTS) is characterized by an excellent prognosis. Drug therapy is necessary in only a minority of patients. Carbamazepine (CBZ) and phenobarbital (PB) have been reported to cause electroclinical aggravation in some cases. The incidence of drug-induced aggravation in BECTS has never been established.
METHODS: We retrospectively studied 98 consecutive cases of BECTS, examined at the Centre Saint Paul between 1984 and 1999; 82 patients had received one or more treatments, often successively and in association.
RESULTS: We found only one case of electroclinical aggravation with CBZ among 40 patients exposed to CBZ (35 in monotherapy, five in polytherapy). An additional case showed a marked EEG aggravation on CBZ + PB among 14 patients taking PB (nine with monotherapy and five with polytherapy), and PB was apparently responsible. No patient treated with valproate or benzodiazepines showed aggravation.
CONCLUSIONS: Aggravation of BECTS caused by antiepileptic drugs happens only rarely. There is a minor risk of aggravation with CBZ and also probably with PB. Drug-induced aggravation may occur only during certain periods coinciding with spontaneous worsening of BECTS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422331     DOI: 10.1046/j.1528-1157.2001.30000.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

1.  Nightly oral administration of topiramate for benign childhood epilepsy with centrotemporal spikes.

Authors:  Chunrong Liu; Mei Song; Jiwen Wang
Journal:  Childs Nerv Syst       Date:  2016-03-16       Impact factor: 1.475

2.  Novel variant in CHRNA4 with benign childhood epilepsy with centrotemporal spikes and contribution to precise medicine.

Authors:  Xiao Neng; Mao Xiao; Chen Yuanlu; Li Qinyan; Shu Li; Song Zhanyi
Journal:  Mol Genet Genomic Med       Date:  2020-04-28       Impact factor: 2.183

3.  A Case of Carbamazepine-Induced Aggravation of Self-Limited Epilepsy with Centrotemporal Spikes Epilepsy and Valproate-Induced Hyperammonemic Encephalopathy in a Child with Heterozygous Gene Variant of Carbomoyl Phosphatase Synthetase Deficiency.

Authors:  Imalke Kankananarachchi; Eresha Jasinge; Gemunu Hewawitharana
Journal:  Case Rep Neurol Med       Date:  2021-12-31

4.  Specific safety and tolerability considerations in the use of anticonvulsant medications in children.

Authors:  Amy Z Crepeau; Brian D Moseley; Elaine C Wirrell
Journal:  Drug Healthc Patient Saf       Date:  2012-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.